Vaultly tag

Novadip Biosciences news and market signals

Public Vaultly articles where Novadip Biosciences appears among the affected assets. Premium market intelligence becomes searchable here after 24 hours.

Novadip Biosciences Raises, 10.4M for Pivotal Trial, Unlocking EIB Funds

StartupsBasic

Medium 7/10Novadip Biosciences Regenerative Medicine Sector

Novadip Biosciences Raises, 10.4M for Pivotal Trial, Unlocking EIB Funds

Belgian biotech firm Novadip Biosciences has secured, 10.4 million in convertible financing, led by New Science Ventures. This funding is earmarked for a pivotal clinical trial and is expected to unlock a tranche from the European Investment Bank (EIB).

September 21, 2026Published 1 hour ago